CONTENTS

        Chapters
  1. Research and Regulatory Approval
  2. Use of Injectables
  3. Effectiveness and Reversibility
  4. Side Effects and Complications
  5. More Evidence in the Cancer Debate
  6. Noncontraceptive Health Benefits
  7. Counseling Issues
  8. Communicating with the Public
  9. Maximizing Access and Quality

Published with this issue:

HIGHLIGHTS


Published by the Population Information Program, Center for Communication Programs, The Johns Hopkins School of Public Health, 111 Market Place, Suite 310, Baltimore, Maryland 21202-4012, USA

Volume XXIII, Number 2 August 1995

Counseling About Side Effects

Program managers may consider a number of factors, some of which conflict, in deciding what providers should tell clients about side effects or should be prepared to discuss with clients. For example:

  • Time. Providers may have just a few minutes to talk with each client and dispense a method. A few extra minutes in initial counseling, however, could save more time later when women return because of unexpected side effects.
  • Clients' reactions to unexpected side effects. People often tolerate side effects that they expect but may discontinue a method if they are surprised by a side effect. Unless clients are told, they have no way to know whether the side effect is minor or serious, or whether it will get worse and threaten their health or instead eventually will diminish or disappear.
  • Clients' reaction to a long list of side effects. Some providers fear that mentioning side effects may discourage clients from using a method (188). Descriptions of serious but rare side effects may be especially frightening to clients. Also, providers should avoid giving clients more information than they can absorb in a short counseling session. Studies in developed countries, however, find that patients, including OC users, generally want detailed information about side effects, while doctors and pharmacists prefer to discuss only serious side effects and the most common minor effects (196, 226). Providers might ask clients if they want to know all the side effects of a drug or procedure or just the ones that are most common (250).
  • Clients' understanding of risk. How can providers make the concept of probability understandable? Describing a slight risk of a serious side effect may be especially difficult. How risks are presented can influence a client's choice. In a study of treatment for lung cancer, for example, both doctors and patients preferred a treatment described as having a 90% survival rate after one year to an identical treatment described as having a 10% mortality rate after one year (203). Thus, family planning providers may point out that, while 5% of users experience a side effect, 95% do not.
  • Cultural or religious customs. These may limit discussion between client and provider. For example, in some cultures clients may not expect to ask questions or to have long discussions with providers, who have higher social status than they do (281). Women may not want to discuss intimate matters with male providers (292). Where possible, managers may arrange for female providers to counsel female clients.
  • Clients' concerns. Providers should be able to reassure clients if they raise concerns about reports in the mass media or rumors from friends or relatives. During education sessions in the McCormick Family Planning Program, for example, providers asked groups of 5 to 15 clients about the rumors that they had heard about DMPA and then provided accurate information (199).

Previous | Next
Top of Page | Table of Contents


111 Market Place, Suite 310, Baltimore, MD 21202, USA
Phone: (410) 659.6300/Fax: (410) 659.6266/E-mail: Poprepts@jhuccp.org

Population Reports